Dental Pain Global Clinical Trials Review, H2, 2017

2017-07-26
Price :
Published : Jul-2017
No. of Pages : 222

Dental Pain Global Clinical Trials Review, H2, 2017

Summary

GlobalData’s clinical trial report, “Dental Pain Global Clinical Trials Review, H2, 2017” provides an overview of Dental Pain clinical trials scenario. This report provides top line data relating to the clinical trials on Dental Pain. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database – Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

– The report provides a snapshot of the global clinical trials landscape
– Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
– The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
– The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
– The Report provides enrollment trends for the past five years
– Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

– Assists in formulating key business strategies with regards to investment
– Helps in identifying prominent locations for conducting clinical trials which saves time and cost
– Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
– Supports understanding of trials count and enrollment trends by country in global therapeutics market
– Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
– Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Filed in: Pharmaceutical
Publisher : GlobalData
More Reports
Title Price Buy Now

Marathon Pharmaceuticals LLC – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Marathon Pharmaceuticals LLC (Marathon Pharmaceuticals) focuses on the development, manufacturing and commercialization of treatments for rare neurological and movement disorders. It develops products in various therapeutic areas which include duchenne muscular dystrophy, pediatric juvenile idiopathic arthritis, neuromyelitis optica, idiopathic inflammatory myopathies, catastrophic pediatric epilepsy and multiple sclerosis. Marathon Pharmaceuticals works in partnership with researchers and patient advocates to develop potential new treatments and also to conduct clinical trials. The company seeks to license or acquire orphan products for the treatment of CNS, neurology and movement disorders. Marathon Pharmaceuticals is headquartered in Northbrook, Illinois, the US. Marathon ......
$250

Elsalys Biotech SAS – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Elsalys Biotech SAS (Elsalys Biotech) is a biotechnology company that designs and develops therapeutic antibodies in oncology and ophthalmology. The company's pipeline products include monoclonal antibodies designed to fight against cancers, vascular eye, idiopathic pulmonary fibrosis and chronic obstructive pulmonary diseases. Its specialization spans from target sourcing to the pre-industrial production of drug candidates. It works in collaboration with academic and other industry partners to conduct programs, clinical evaluation of antibody candidates and to develop immune-based therapies. The company owns and operates laboratories located in the Illkirch Graffenstaden Science and Technology Park. Elsalys Biotech is headquartered in Lyon, France. Elsalys Biotech SAS - Phar......
$250

MEI Pharma Inc (MEIP) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary MEI Pharma Inc (MEI), formerly Marshall Edwards Inc is an oncology company that offers clinical development of novel therapies for cancer. The company's drug candidates comprise pracinostat, an oral HDAC inhibitor which is intended for the treatment of acute myeloid leukemia, myelodysplastic syndrome and myelofibrosis. Its also develops ME-344, a mitochondrial inhibitor for the treatment of HER2-negative Breast indication; and ME-401, an oral PI3K delta inhibitor for B-cell malignancies. The company partners with other drug developers to produce Pracinostat in AML and myelodysplastic syndrome indications. MEI is headquartered in San Diego, California, the US. MEI Pharma Inc (MEIP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and......
$250

Idexx Laboratories Inc (IDXX) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Idexx Laboratories Inc (IDEXX) is a diagnostics company. It develops, manufactures and distributes products and services for small animals and livestock. The company offers veterinary reference laboratory diagnostics and consulting services, point-of-care veterinary diagnostic products, microbiological contaminant testing products (in water), livestock and poultry diagnostic and health-monitoring products, antibiotic residue testing products (in milk), and practice management systems and services. IDEXX also sells a line of portable electrolytes and blood gas analyzers for the human point-of-care medical diagnostics market. The company offers its products to veterinary, equine, livestock and poultry, water testing and dairy markets. It operates in the Americas, Europe, the Middl......
$250

FUDAN University – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary FUDAN University (FUDAN) is an educational university that offers bachelor, undergraduate, master and doctoral degrees in various disciplines. The university confers bachelor's degrees in multiple academic disciplines. It conducts research in various disciplines such as natural sciences, department planning, engineering and medicine, humanities and social sciences, and others. FUDAN operates through departments of philosophy, economics, law, education, literature, history, science, engineering, medicine, and management. The university hosts hundred research institutes that include national key labs and eight ministerial, provincial key labs and engineering centers. It also includes campus including Zhangjiang Campus and Fenglin Campus. FUDAN is headquartered in Shanghai, China. ......
$250

Curevac AG – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Curevac AG (Curevac), formerly CureVac GmbH is a clinical stage biopharmaceutical company that develops RNA-based medicines. The company designs, develops and produces messenger RNA molecules for therapeutic and prophylactic vaccines in the fields of oncology and infectious diseases. Its RNA technology platforms include RNAntibody, RNArt, RNActive, and RNAdjuvant. Curevac's RNActive technology is used to develop treatments against cancer and prophylactic vaccines for infectious diseases. The company's RNAdjuvant technology is used to enhance the immune response of other vaccines. Its products are used in the treatment of prostate cancer and non-small cell lung cancer; and infectious diseases such as rabies, rotavirus, influenza, and other undisclosed. The company program the RNA......
$250

Intrexon Corp (XON) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Intrexon Corp (Intrexon), formerly Genomatix Corp is a provider of therapeutic solutions. The company operates through its divisions such as human therapeutics, protein production, industrial products, agricultural biotech, and animal sciences. Its human therapeutics division develops therapeutic product candidates for lysosomal storage diseases, hematological disorders, metabolic diseases, infectious diseases, and autoimmune disorders. Intrexon's UltraVector platform produces and optimizes custom, complex gene systems; mAbLogix platform enables production of B-cell libraries for discovery of antibodies. The company offers RheoSwitch therapeutic system for inducible expression of single and multi-gene systems through an activator ligand. It has partnership with the channel of ne......
$250

Medimetriks Pharmaceuticals Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Medimetriks Pharmaceuticals Inc (MPI) is a drug company that offers skincare products. The company provides personal care products including cleansers, nutritional suppliments, cosmetic creams, and moisturizer. Its products include Centany, Ciclodan, Clindacin ETZ, Genadur, Ketodan, Morgidox, Uramaxin and Rosadan. MPI offers products for the treatment of acne, seborrheic dermatitis, severe dry skin, dystrophic nails and impetigo. The company develops and commercializes skincare products in the Dermatology and Podiatry markets. It also offers products for hair care. The company operates across various states in the US. MPI is headquartered in Fairfield, New Jersey, the US. Medimetriks Pharmaceuticals Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you......
$250

International AIDS Vaccine Initiative – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary International AIDS Vaccine Initiative (IAVI) is a not-for-profit organization that develops preventive HIV vaccine candidates. The organization offers vaccine development through basic research, discovery, preclinical evaluation and manufacturing, and regulatory review, among others. It also conducts policy analysis and performs vaccine trials and epidemiological research. IAVI's product portfolio includes mRNA-NFL, BG505 Envelope, eOD Immunogen, AAV-PG9, AD26, MVA, protein and CDV replicating vector, among others. The organization partners with academic, industry and government organizations and clinical research center. It operates in South Africa, Kenya, India, the US, and the Netherlands. IAVI is headquartered in New York, the US. International AIDS Vaccine Initiative - P......
$250

Laboratorio Teuto Brasileiro SA – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Laboratorio Teuto Brasileiro SA (Teuto), a subsidiary of Pfizer Inc is a drug company that develops, manufactures, and markets generic and over the counter products. The company's products include aerodini aerosol salbutamol sulphate, afopic folic acid, albentel albendazole, acetato de dexametasona, acetato de hidrocortisona, acetilcisteina, and aciclovir creme, among others. It also provides phytotherapic medicines, food supplements, cosmetics, and hospital line products. Teuto offers its products in the form of liquids, injectables, and eye drops. The company provides outsourced pharmaceutical manufacturing services to national and multinational companies. It markets its products to customers in Central America, South America, and Portugal, among others. Teuto is headquartered......
$250